IO Biotech, Inc. (IOBT): Price and Financial Metrics
IOBT Price/Volume Stats
| Current price | $0.77 | 52-week high | $2.10 |
| Prev. close | $0.76 | 52-week low | $0.66 |
| Day low | $0.75 | Volume | 214,700 |
| Day high | $0.78 | Avg. volume | 262,369 |
| 50-day MA | $0.99 | Dividend yield | N/A |
| 200-day MA | $1.26 | Market Cap | 50.79M |
IOBT Stock Price Chart Interactive Chart >
IO Biotech, Inc. (IOBT) Company Bio
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops disruptive immune modulating anti-cancer therapies in Denmark. The company's lead product candidate, IO102-IO103, is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death ligand (PD-L1). It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. IO Biotech, Inc. was incorporated in 2021 and is based in Copenhagen, Denmark.
IOBT Price Returns
| 1-mo | 12.90% |
| 3-mo | -31.86% |
| 6-mo | -35.29% |
| 1-year | -48.67% |
| 3-year | -90.48% |
| 5-year | N/A |
| YTD | -59.04% |
| 2023 | -18.26% |
| 2022 | -64.06% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...